Literature DB >> 34107600

Reference Values for Skeletal Muscle Mass at the Third Lumbar Vertebral Level Measured by Computed Tomography in a Healthy Korean Population.

Ja Kyung Yoon1, Sunyoung Lee1, Kyoung Won Kim2, Ji Eun Lee3, Jeong Ah Hwang4, Taeyong Park5, Jeongjin Lee5.   

Abstract

BACKGROUND: Sarcopenia is defined as the loss of skeletal muscle mass and is associated with negative clinical outcomes. This study aimed to establish sex-specific cutoff values for the skeletal muscle area (SMA) and skeletal muscle index (SMI) at the third lumbar vertebral (L3) level using computed tomography (CT) imaging to identify sarcopenia in healthy Korean liver donors.
METHODS: This retrospective study included 659 healthy liver donors (408 men and 251 women) aged 20 to 60 years who had undergone abdominal CT examinations between January 2017 and December 2018. Assessment of body composition was performed with an automated segmentation technique using a deep-learning system. Sex-specific SMA and SMI distributions were assessed, and cutoff values for determining sarcopenia were defined as values at either two standard deviations (SDs) below the mean reference value or below the fifth percentile.
RESULTS: Using the SD definition, cutoff values for SMA and SMI were 117.04 cm2 and 39.33 cm2/m2, respectively, in men and 71.39 cm2 and 27.77 cm2/m2, respectively, in women. Using the fifth percentile definition, cutoff values for SMA and SMI were 126.88 cm2 and 40.96 cm2/m2, respectively, in men and 78.85 cm2 and 30.60 cm2/m2, respectively, in women.
CONCLUSION: Our data provide sex-specific cutoff values for the SMA and SMI at the L3 level measured by CT imaging in a healthy Korean population, which may be applicable for identifying sarcopenia in this population.

Entities:  

Keywords:  Multidetector computed tomography; Muscle, skeletal; Reference values; Sarcopenia

Mesh:

Year:  2021        PMID: 34107600      PMCID: PMC8258333          DOI: 10.3803/EnM.2021.1041

Source DB:  PubMed          Journal:  Endocrinol Metab (Seoul)        ISSN: 2093-596X


INTRODUCTION

Sarcopenia is defined as the generalized and progressive loss of skeletal muscle mass (SMM) and muscle strength associated with metabolic, physiologic, and functional impairments and poor clinical outcomes, including increased mortality and disability and a reduced quality of life [1-3]. Despite its clinical significance, the evaluation of sarcopenia has been hindered by a diversity of measurement methods, including dual energy X-ray absorptiometry (DXA), bioelectric impedance analysis (BIA), magnetic resonance imaging, and computed tomography (CT) imaging. The most widely used assessment tool for SMM is DXA, and sex-specific cutoff values have been established for this technique using the appendicular skeletal muscle index (SMI; appendicular SMM/height2) [2-4]. CT imaging is considered a gold standard for the evaluation of body composition, and cross-sectional muscle areas of specific muscles or body locations is an easily applicable method for measuring the SMM using CT imaging [2,3]. Quantitative measurements of the cross-sectional skeletal muscle area (SMA) and SMI (SMA/height2) using CT imaging are most commonly assessed at the level of the third lumbar vertebra (L3) and are known to significantly correlate with whole-body muscle [3,5,6]. Cutoff values for the SMI at the L3 level using CT imaging have been reported in healthy Western populations [7,8]. In addition, recent studies have suggested that the psoas muscle area measured by CT imaging can be a simple method for identifying sarcopenia [3]. In healthy Asian populations, cutoff values for the psoas muscle index (PMI) at the L3 level have been proposed, although using such a small muscle for assessing the total SMM is controversial [9,10]. However, cutoff values for the SMA and SMI at the L3 level on CT scans have not been reported for sarcopenia in healthy Korean liver donors thus far. Therefore, this study aimed to establish sex-specific cutoff values for the SMA and SMI at the L3 level using CT imaging to identify sarcopenia in healthy Korean liver donors.

METHODS

The study was approved by the Institutional Review Board of Asan Medical Center (AMC 2021-0473). The requirement for written informed consent was waived due to the retrospective nature of the analysis.

Study population

Subjects aged 20 to 60 years who had undergone abdominal CT examinations as part of an evaluation for liver donation from January 2017 to December 2018 were retrospectively identified. Data on patient age, sex, weight, and height from just before the date of CT examinations were collected from the medical record. Subjects who had fully visible abdominal muscles at the L3 level on CT imaging and who were deemed healthy enough to undergo organ donation were included in this study.

CT image acquisition

CT scans were performed using a 128-slice (Definition AS+ or edge, Siemens, Erlangen, Germany) multidetector-row CT scanner. Unenhanced CT scans were obtained, followed by biphasic contrast-enhanced CT imaging (hepatic arterial phase and portal venous phase) after administration of 150 mL of iopromide (Ultravist 370, Bayer Schering Pharma, Berlin, Germany) for anatomical mapping of the hepatic vasculature and CT volumetry. The scanning and reconstruction parameters were as follows: beam collimation of 128 slices (0.6 mm); spiral pitch of 1; gantry rotation time of 0.5 second; tube voltage of 100 or 120 kVp; and tube current of 120 to 200 mAs with automatic exposure control (Care Dose 4D, Siemens) and a section thickness and interval of 5 mm.

Assessment of skeletal muscle parameters

A single axial CT image at the level of the inferior endplate of the L3 vertebra was processed for each patient. Abdominal CT image analyses were conducted with a fully convolutional network-based automatic segmentation technique using a deep-learning system [11]. The body composition was assessed using artificial intelligence software (AID-U™, iAID Inc., Seoul, Korea) [11]. CT images were automatically segmented to generate boundaries, and the total abdominal muscle area was measured. The SMA (cm2), including all muscles on selected axial images (i.e., psoas, paraspinals, transversus abdominis, rectus abdominis, quadratus lumborum, and internal and external oblique muscles) were demarcated using predetermined thresholds (−29 to 150 Hounsfield units) (Fig. 1). SMI was normalized to stature by dividing the muscle area by the height squared, as follows: SMA (cm2)/height (m2).
Fig. 1

Cross-sectional computed tomographic images at the third lumbar vertebral level. Skeletal muscle area was quantified using the threshold values of −29 to 150 Hounsfield units.

Statistical analysis

Shapiro-Wilk and Kolmogorov-Smirnov normality tests were used to determine the normality of age, weight, height, and body mass index (BMI). A two-sample t test was used for parametric variables (height), while the Mann-Whitney U test was used for non-parametric variables (age, weight, and BMI). Cutoff values for determining sarcopenia were defined as those at either two standard deviations (SDs) below the mean reference value or below the fifth percentile [1-3,7]. Statistical analyses were performed using SPSS version 23.0 (IBM, Armonk, NY, USA). A P≤0.05 was considered statistically significant.

RESULTS

The baseline subject characteristics are shown in Table 1. A total of 659 healthy liver donors (mean age±SD, 31.5±8.3 years) were included in the analysis, consisting of 408 (61.9%) men and 251 (38.1%) women. The mean age was significantly lower in men than in women (30.2 years vs. 33.5 years, P<0.001). Men were significantly heavier (73.0 kg vs. 59.1 kg, P<0.001) and taller (174.5 cm vs. 161.7 cm, P<0.001) than women.
Table 1

Subject Characteristics

CharacteristicTotalMenWomenP value
Aged 20–60 yr659408251
 Age, yr
  Mean±SD31.5±8.330.2±6.133.5±8.2<0.001a
  Median30.028.033.0
  Range20–5920–5920–59
 Weight, kg
  Mean±SD67.7±12.073.0±10.159.1±9.6<0.001a
  Median67.872.657.0
  Range40.1–118.149.6–118.140.1–90.0
 Height, cm
  Mean±SD169.6±8.5174.5±6.1161.7±5.3<0.001b
  Median170.2174.6161.8
  Range148.1–193.4154.0–193.4148.1–175.2
 BMI, kg/m2
  Mean±SD23.4±3.123.9±2.822.6±3.4<0.001a
  Median23.323.722.1
  Range16.1–38.316.1–38.316.4–35.2

Aged 20–40 yr560358202
  Age, yr
  Mean±SD28.9±5.627.9±5.330.5±5.8<0.001a
  Median28.028.031.0
  Range20–3920–3920–39
 Weight, kg
  Mean±SD68.0±12.172.9±10.359.3±9.8<0.001a
  Median67.972.557.4
  Range40.5–118.149.6–118.140.5–90.0
 Height, cm
  Mean±SD170.3±8.3174.8±5.9162.3±5.1<0.001b
  Median170.9174.7162.1
  Range148.1–193.4161.0–193.4148.1–175.2
 BMI, kg/m2
  Mean±SD23.4±3.123.8±2.822.5±3.4<0.001a
  Median23.323.722.0
  Range16.1–38.316.1–38.316.4–35.2

SD, standard deviation; BMI, body mass index.

Mann-Whitney U test was used;

Two-sample t test was used.

When the SD definition was used for defining sarcopenia in subjects aged 20 to 60 years, the cutoff values for SMA and SMI were 117.04 cm2 and 39.33 cm2/m2, respectively, in men and 71.39 cm2 and 27.77 cm2/m2, respectively, in women. For the subgroup of subjects aged 20 to 40 years, the cutoff values for SMA and SMI were 118.42 cm2 and 39.79 cm2/m2, respectively, in men and 70.11 cm2 and 27.22 cm2/m2, respectively, in women (Table 2).
Table 2

Sex-Specific Cutoff Values Using the Definition of Two Standard Deviations below the Mean for Skeletal Muscle Parameters

VariableMenWomen


Mean±SDCutoff valueMean±SDCutoff value
SMA, cm2
 Aged 20–60 yr161.01±21.98117.04102.11±15.3671.39
 Aged 20–40 yr162.06±21.82118.42102.13±16.0170.11

SMI, cm2/m2
 Aged 20–60 yr52.89±6.7839.3339.06±5.6527.77
 Aged 20–40 yr53.05±6.6339.7938.78±5.7827.22

SD, standard deviation; SMA, skeletal muscle area; SMI, skeletal muscle index.

Sex-specific mean, median, minimum, maximum, and percentile values for SMA and SMI are shown in Table 3. When the fifth percentile definition was used for determining sarcopenia in subjects aged 20 to 60 years, the cutoff values for SMA and SMI were 126.88 cm2 and 40.96 cm2/m2, respectively, in men and 78.85 cm2 and 30.60 cm2/m2, respectively, in women. In the subgroup of subjects aged 20 to 40 years, the fifth percentile cutoff values for SMA and SMI were 127.99 cm2 and 42.71 cm2/m2, respectively, in men and 78.68 cm2 and 30.27 cm2/m2, respectively, in women (Table 3).
Table 3

Sex-Specific Measurement Results and Percentiles for Skeletal Muscle Parameters at the L3 Level

VariableMenWomen


SMA, cm2SMI, cm2/m2SMA, cm2SMI, cm2/m2
Aged 20–60 yr408251
 Mean161.0152.89102.1139.06
 Median160.3252.63101.1038.65
 Minimum90.8533.2165.9727.00
 Maximum247.3472.06158.4155.27
 Percentiles
  5126.8840.9678.8530.60
  10132.7044.8083.0432.01
  25145.9548.3491.4834.93
  50160.3252.63101.1038.65
  75175.0657.29111.8442.62
  90188.6361.73120.9947.05
  95198.0664.93131.0150.10

Aged 20–40 yr358202
 Mean162.0653.05102.1338.78
 Median161.2252.86100.8238.15
 Minimum106.0533.2170.1527.00
 Maximum247.3472.06158.4155.27
 Percentiles
  5127.9942.7178.6830.27
  10133.3744.8481.8131.63
  25146.4448.5691.3934.43
  50161.2552.86100.8238.15
  75176.2957.33111.1142.16
  90188.9361.59124.4046.62
  95199.4264.88133.7350.42

L3, lumbar vertebra; SMA, skeletal muscle area; SMI, skeletal muscle index.

DISCUSSION

In our study, sex-specific SMI cutoff values for defining sarcopenia in healthy Korean liver donors using the SD definition at the L3 level of CT scans were 39.33 cm2/m2 in men and 27.77 cm2/m2 in women. Sex-specific SMI cutoff values using the fifth percentile definition were 40.96 cm2/m2 and 30.60 cm2/m2 in men and women, respectively. Previous studies have proposed cutoff values using the PMI at the L3 level on CT scans in a healthy Korean population and in healthy Japanese liver donor subjects [9,10]. Although significant associations between the PMI and SMI have been reported using BIA results, SMI is known to be more accurate for assessing SMM than PMI [6,9]. Previous studies have suggested that a single SMA at the L3 level is the best compromise site for assessing total skeletal muscle and a valid proxy for assessing whole-body skeletal muscle [5,6]. Moreover, the use of the PMI to determine whole-body skeletal muscle is controversial because of the relatively small size of this muscle [3,4]. Using the SD definition, various ranges for sex-specific cutoff values for SMI at the L3 level on CT scans have been suggested in healthy populations with different ethnicities [8,12,13]. In the present study, the sex-specific cutoff values using this definition were lower than those derived from both healthy kidney donors in the United States (45.4 cm2/m2 in men and 34.4 cm2/m2 in women) and in Turkey (42.6 cm2/m2 in men and 33.9 cm2/m2 in women) [8,13]. In healthy Asian Indians, the cutoff values using this definition were 36.5 cm2/m2 in men and 30.2 cm2/m2 in women [12]. Cutoff values for the SMI at the L3 level on CT scans using the fifth percentile definition in potential kidney donors were 41.6 cm2/m2 in men and 32.0 cm2/m2 in women in a Caucasian population, both higher than the fifth percentile cutoffs in this study [7]. In a Turkish population, the fifth percentile cutoffs were 45.0 cm2/m2 in men and 36.1 cm2/m2 in women aged 20 to 60 years old and 45.5 cm2/m2 in men and 36.2 cm2/m2 in women aged 20 to 40 years old [13]. These cutoffs were also higher than the sex-specific fifth percentile cutoff values in the respective age groups in our study [13]. These discrepant findings may be attributable to differences in ethnicity, body size, lifestyle, or culture [2,3,14,15]. This study had several limitations. First, its retrospective design introduced an inherent bias. Second, recruiting this population of organ donors from a university hospital may have induced selection biases related to socioeconomic status and patient characteristics. In addition, since the study population of liver donors are usually in better health than the average healthy population, it may not be representative of the general healthy population. Living liver donors undergo extensive screening and they must not have diabetes nor even fatty liver. Therefore, muscle mass in this population might be overestimated. Lastly, whether the physical activity levels or muscular strength of subjects can influence the diagnosis of sarcopenia was not assessed. In conclusion, our data provide sex-specific cutoff values for the SMA and SMI at the L3 level measured by CT imaging in a healthy Korean population which may be applicable for identifying sarcopenia in the Korean population.
  14 in total

1.  Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia.

Authors:  Liang-Kung Chen; Li-Kuo Liu; Jean Woo; Prasert Assantachai; Tung-Wai Auyeung; Kamaruzzaman Shahrul Bahyah; Ming-Yueh Chou; Liang-Yu Chen; Pi-Shan Hsu; Orapitchaya Krairit; Jenny S W Lee; Wei-Ju Lee; Yunhwan Lee; Chih-Kuang Liang; Panita Limpawattana; Chu-Sheng Lin; Li-Ning Peng; Shosuke Satake; Takao Suzuki; Chang Won Won; Chih-Hsing Wu; Si-Nan Wu; Teimei Zhang; Ping Zeng; Masahiro Akishita; Hidenori Arai
Journal:  J Am Med Dir Assoc       Date:  2014-02       Impact factor: 4.669

2.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

3.  Physical activity and incidence of sarcopenia: the population-based AGES-Reykjavik Study.

Authors:  Donja M Mijnarends; Annemarie Koster; Jos M G A Schols; Judith M M Meijers; Ruud J G Halfens; Vilmundur Gudnason; Gudny Eiriksdottir; Kristin Siggeirsdottir; Sigurdur Sigurdsson; Pálmi V Jónsson; Osorio Meirelles; Tamara Harris
Journal:  Age Ageing       Date:  2016-05-17       Impact factor: 10.668

4.  A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care.

Authors:  Marina Mourtzakis; Carla M M Prado; Jessica R Lieffers; Tony Reiman; Linda J McCargar; Vickie E Baracos
Journal:  Appl Physiol Nutr Metab       Date:  2008-10       Impact factor: 2.665

5.  Simple Age Specific Cutoff Value for Sarcopenia Evaluated by Computed Tomography.

Authors:  Ji Sun Kim; Won Young Kim; Hyun Kyung Park; Myung Chun Kim; Woong Jung; Byuk Sung Ko
Journal:  Ann Nutr Metab       Date:  2017-09-08       Impact factor: 3.374

Review 6.  Diet Quality and Sarcopenia in Older Adults: A Systematic Review.

Authors:  Ilse Bloom; Calum Shand; Cyrus Cooper; Sian Robinson; Janis Baird
Journal:  Nutrients       Date:  2018-03-05       Impact factor: 6.706

7.  Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population.

Authors:  Brian A Derstine; Sven A Holcombe; Brian E Ross; Nicholas C Wang; Grace L Su; Stewart C Wang
Journal:  Sci Rep       Date:  2018-07-27       Impact factor: 4.379

8.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

9.  Percentiles for skeletal muscle index, area and radiation attenuation based on computed tomography imaging in a healthy Caucasian population.

Authors:  A van der Werf; J A E Langius; M A E de van der Schueren; S A Nurmohamed; K A M I van der Pant; S Blauwhoff-Buskermolen; N J Wierdsma
Journal:  Eur J Clin Nutr       Date:  2017-12-15       Impact factor: 4.016

Review 10.  Reference Values for Skeletal Muscle Mass - Current Concepts and Methodological Considerations.

Authors:  Carina O Walowski; Wiebke Braun; Michael J Maisch; Björn Jensen; Sven Peine; Kristina Norman; Manfred J Müller; Anja Bosy-Westphal
Journal:  Nutrients       Date:  2020-03-12       Impact factor: 5.717

View more
  3 in total

1.  Computed Tomography-Derived Skeletal Muscle Radiodensity Is an Early, Sensitive Marker of Age-Related Musculoskeletal Changes in Healthy Adults.

Authors:  Yeon Woo Jung; Namki Hong; Joon Chae Na; Woong Kyu Han; Yumie Rhee
Journal:  Endocrinol Metab (Seoul)       Date:  2021-12-13

Review 2.  Assessment of Muscle Quantity, Quality and Function.

Authors:  Bo Kyung Koo
Journal:  J Obes Metab Syndr       Date:  2022-03-30

Review 3.  The Value of Artificial Intelligence-Assisted Imaging in Identifying Diagnostic Markers of Sarcopenia in Patients with Cancer.

Authors:  Ying-Tzu Huang; Yi-Shan Tsai; Peng-Chan Lin; Yu-Min Yeh; Ya-Ting Hsu; Pei-Ying Wu; Meng-Ru Shen
Journal:  Dis Markers       Date:  2022-03-29       Impact factor: 3.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.